If you have a child who constantly fights bedtime, interrupts your sleep at night, or frequently seems to have difficulties falling asleep, chances are you've at least thought about administering a ...
Researchers in a recent study have identified alarming trends among adults who increasingly rely on substances as sleep aids. According to data from the University of Michigan's annual Monitoring the ...
The best sleep apps, like Calm and Headspace, support healthier sleep habits by offering guided relaxation, soothing ...
A generic melatonin product, Melatomed (Fairmed Healthcare GmbH), has received positive recommendation for managing sleep disorders in adults 55 years or older from the European Medicines Agency’s ...
A night of solid rest can feel like a panacea. The quantity and quality of our sleep influence our physical health, our moods, our cognition and our ability to function in almost every aspect of life.
The FDA clearance follows the presentation of SANSA clinical performance data earlier this year at the SLEEP meeting. The study, drawing on data collected from 325 patients across 7 clinical sites, ...
An unpublished study presented at a recent American Heart Association meeting found that people taking melatonin had a 4.6% risk of heart failure, compared to a 2.7% risk among people who did not take ...
Dear Dr. Roach: I am an 82-year-old female who has a hard time staying asleep. I have been taking melatonin to help. I read recently that if you have taken melatonin for a long time, you could have a ...
The MarketWatch News Department was not involved in the creation of this content. ATLANTA, Dec. 17, 2025 /PRNewswire/ -- Huxley Medical, Inc. today announced the U.S. Food and Drug Administration (FDA ...
Insomnia can be a literal killer. So can a noisy brain. The American Academy of Sleep Medicine says you need at least seven hours of shut-eye a night, but that's a lot easier said than done when your ...
MarketBeat on MSN
Palantir Technologies: Another Stellar Year Ahead for the Stock?
Palantir Technologies (NASDAQ: PLTR) was the standout and number one performer in the S&P 500 in 2024, with its stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback